Gideon Bollag
11Patents
9h-index
31Co-inventors
72Inventor score
Filing activity: May 15, 1998 → Aug 4, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7863288B2 | Compounds and methods for kinase modulation, and indications therefor | Chemistry; Metallurgy | 147 | Active |
| US8143271B2 | Compounds and methods for kinase modulation, and indications therefor | Chemistry; Metallurgy | 114 | Active |
| US8470818B2 | Compounds and methods for kinase modulation, and indications therefor | Chemistry; Metallurgy | 87 | Active |
| US8415469B2 | Compounds and methods for kinase modulation, and indications therefor | Chemistry; Metallurgy | 81 | Active |
| US9358235B2 | Kinase modulation, and indications therefor | Human Necessities | 39 | Active |
| US9550768B2 | Kinase modulation and indications therefor | Human Necessities | 38 | Active |
| US7307071B2 | RAF-MEK-ERK pathway inhibitors to treat cancer | Human Necessities | 22 | Expired |
| US9730918B2 | Kinase modulation, and indications therefor | Human Necessities | 22 | Active |
| US9814714B2 | Kinase modulation, and indications therefor | Human Necessities | 21 | Active |
| US10123998B2 | Kinase modulation, and indications therefor | Human Necessities | 8 | Active |
| US6340575B1 | Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.